S
PLRX icon

SignatureFD’s Pliant Therapeutics PLRX Stock Holding History

SignatureFD’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-124
Closed -$1.63K – 3416
2024
Q4 		$1.63K Hold
124
– – ﹤0.01% 2923
2024
Q3 		$1.39K Buy
+124
New +$1.55K ﹤0.01% 2926
2024
Q2 		– Sell
-417
Closed -$6.21K – 3229
2024
Q1 		$6.21K Sell
417
-37
-8% -$610 ﹤0.01% 2478
2023
Q4 		$8.22K Sell
454
-143
-24% -$2.17K ﹤0.01% 2339
2023
Q3 		$10.4K Buy
597
+500
+515% +$8.67K ﹤0.01% 2199
2023
Q2 		$1.76K Buy
97
+38
+64% +$900 ﹤0.01% 2849
2023
Q1 		$1.57K Sell
59
-37
-39% -$1.05K ﹤0.01% 2871
2022
Q4 		$1.86K Sell
96
-83
-46% -$1.74K ﹤0.01% 2832
2022
Q3 		$4K Buy
179
+120
+203% +$2.3K ﹤0.01% 2555
2022
Q2 		$0 Buy
+59
New +$378 ﹤0.01% 3292

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

SignatureFD's PLRX Position: Q1 2025 in Review

SignatureFD sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 124 shares — an estimated $1.63K sold.

SignatureFD first reported a position in PLRX in Q2 2022 and held it in 10 quarters. The position peaked at $10.4K in Q3 2023. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

  • SignatureFD reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
  • SignatureFD sold 124 Pliant Therapeutics shares in Q1 2025, an estimated $1.63K.
  • SignatureFD first reported a position in Pliant Therapeutics in Q2 2022 and held it in 10 quarters.
  • SignatureFD's Pliant Therapeutics position peaked at $10.4K in Q3 2023.
  • 140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on SignatureFD's 13F filing for Q1 2025, filed 2 May 2025.